Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

500 participants

Study Classification

OBSERVATIONAL

Study Start Date

2024-07-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This research study aims to address the limited understanding of the challenges faced by specific demographic groups of chronic lymphocytic leukemia patients in their participation in clinical trials.

This trial will scrutinize the experiences of patients diagnosed with chronic lymphocytic leukemia as they take part in a separate medical intervention clinical trial. The focus will be on tracking the rates of completion and withdrawal among these individuals.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chronic lymphocytic leukemia patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Understanding Chronic Lymphocytic Leukemia

NCT04028531

Chronic Lymphocytic Leukemia

RECRUITING

Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

NCT01433965

Acute Myeloid Leukemia Myelodysplastic Syndrome

COMPLETED PHASE1

Lenalidomide in Patients With Chronic Lymphocytic Leukemia Older Than 65 Years of Age

NCT01011894

Chronic Lymphocytic Leukemia Leukemia

COMPLETED PHASE2

Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission

NCT00899899

Leukemia

COMPLETED

Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.

NCT00466895

Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Chronic Lymphocytic Leukemia

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Chronic Lymphocytic Leukemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CROSSOVER

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient has been diagnosed with chronic lymphocytic leukemia
* Patient is a minimum of 18 years or older
* Able to comprehend the investigational nature of the protocol and provide informed consent

Exclusion Criteria

* Pregnant or lactating women
* Patients who are currently receiving any other investigational drug
* Any mental or medical condition that prevents the patient from giving informed consent or participating in the trial

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No